Press Release – ONL Therapeutics

ANN ARBOR, MI – February 11, 2016 – ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, today announced [...]

By onl101

In Press Release

Posted October 29, 2015

ONL Therapeutics to Present at the 2015 Ophthalmology Innovation Summit at the American Academy of Ophthalmology Annual Meeting

ANN ARBOR, MI – October 29, 2015 – ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, today announced [...]

By onl101

In Press Release

Posted October 14, 2015

ONL Therapeutics Announces Formation of Scientific Advisory Board

Renowned Retinal Disease Thought Leaders to Help Guide Development of Novel Vision Protection Technology in Age-Related Macular Degeneration (AMD) and Retinal Detachment ANN ARBOR, MI – [...]

By onl101

In Press Release

Posted June 15, 2015

ONL Therapeutics Provides Update on Novel Photoreceptor Protection Platform for Retinal Diseases

Company Promotes Lead Development Compound and Expands Clinical Program to Include Dry and Wet Age-Related Macular Degeneration (AMD) ANN ARBOR, MI – June 15, 2015 – ONL Therapeutics, [...]

By onl101

In Press Release

Posted March 12, 2015

ONL Therapeutics to Present at Upcoming Investor and Scientific Conferences

ANN ARBOR, MI – March 12, 2015 – ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for preserving sight in a range of retinal diseases, today announced [...]

By onl101

In Press Release

Posted December 3, 2014

ONL Therapeutics Announces Management Team Additions

Company Strengthens Leadership by Naming Chief Science Officer, Chief Medical Officer and SVP of Operations ANN ARBOR, MI – December 3, 2014 – ONL Therapeutics, Inc., a biopharmaceutical company [...]